Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rami Komrokji

Showing results (31-40 of 129) with videos related to

Pageof 13
Sort By:
Journal of Vascular and Interventional Radiology : JVIR|September 1, 2019
Partial Splenic Artery Embolization in 35 Cancer Patients: Results of a Single Institution Retrospective StudyBela Kis, Matthew Mills, Johnna Smith, et al.
Blood Cancer Journal|November 15, 2022
Evaluating complete remission with partial hematologic recovery (CRh) as a response criterion in myelodysplastic syndromes (MDS)Andrew M Brunner, Alexander Gavralidis, Najla Al Ali, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 23, 2015
Validation of the Lower-Risk MD Anderson Prognostic Scoring System for Patients With Myelodysplastic SyndromeRami Komrokji, Hanadi Ramadan, Najla Al Ali, et al.
Hematology (Amsterdam, Netherlands)|May 24, 2021
Impact of obesity on survival of patients with myelodysplastic syndromesZaker Schwabkey, Najla Al Ali, David Sallman, et al.
American Journal of Hematology|July 30, 2004
Donor cell myelodysplastic syndrome after allogeneic stem cell transplantation responding to donor lymphocyte infusion: case report and literature reviewRami Komrokji, Jainulabdeen J Ifthikharuddin, Raymond E Felgar, et al.
The Journal of Clinical Investigation|January 22, 2020
Biological basis for efficacy of activin receptor ligand traps in myelodysplastic syndromesAmit Verma, Rajasekhar Nvs Suragani, Srinivas Aluri, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
Myelodysplastic Syndromes in Adolescent Young Adults: One Institution's ExperienceJoanna Grabska, Bijal Shah, Damon Reed, et al.
Leukemia & Lymphoma|January 3, 2013
A multicenter phase II trial to determine the safety and efficacy of combination therapy with denileukin diftitox and cyclophosphamide, doxorubicin, vincristine and prednisone in untreated peripheral T-cell lymphoma: the CONCEPT studyFrancine M Foss, Nelida Sjak-Shie, Andre Goy, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 4, 2022
Comparison of Different Treatment Strategies for Blast-Phase Myeloproliferative NeoplasmsFranco Castillo Tokumori, Najla Al Ali, Onyee Chan, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 12, 2020
Retrospective Analysis of the Clinical Use and Benefit of Lenalidomide and Thalidomide in MyelofibrosisFranco Castillo-Tokumori, Chetasi Talati, Najla Al Ali, et al.
Pageof 13

Showing results (31-40 of 129) with videos related to

Sort By:
Pageof 13
Journal of Vascular and Interventional Radiology : JVIR|September 1, 2019
Partial Splenic Artery Embolization in 35 Cancer Patients: Results of a Single Institution Retrospective StudyBela Kis, Matthew Mills, Johnna Smith, et al.
Blood Cancer Journal|November 15, 2022
Evaluating complete remission with partial hematologic recovery (CRh) as a response criterion in myelodysplastic syndromes (MDS)Andrew M Brunner, Alexander Gavralidis, Najla Al Ali, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 23, 2015
Validation of the Lower-Risk MD Anderson Prognostic Scoring System for Patients With Myelodysplastic SyndromeRami Komrokji, Hanadi Ramadan, Najla Al Ali, et al.
Hematology (Amsterdam, Netherlands)|May 24, 2021
Impact of obesity on survival of patients with myelodysplastic syndromesZaker Schwabkey, Najla Al Ali, David Sallman, et al.
American Journal of Hematology|July 30, 2004
Donor cell myelodysplastic syndrome after allogeneic stem cell transplantation responding to donor lymphocyte infusion: case report and literature reviewRami Komrokji, Jainulabdeen J Ifthikharuddin, Raymond E Felgar, et al.
The Journal of Clinical Investigation|January 22, 2020
Biological basis for efficacy of activin receptor ligand traps in myelodysplastic syndromesAmit Verma, Rajasekhar Nvs Suragani, Srinivas Aluri, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
Myelodysplastic Syndromes in Adolescent Young Adults: One Institution's ExperienceJoanna Grabska, Bijal Shah, Damon Reed, et al.
Leukemia & Lymphoma|January 3, 2013
A multicenter phase II trial to determine the safety and efficacy of combination therapy with denileukin diftitox and cyclophosphamide, doxorubicin, vincristine and prednisone in untreated peripheral T-cell lymphoma: the CONCEPT studyFrancine M Foss, Nelida Sjak-Shie, Andre Goy, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 4, 2022
Comparison of Different Treatment Strategies for Blast-Phase Myeloproliferative NeoplasmsFranco Castillo Tokumori, Najla Al Ali, Onyee Chan, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 12, 2020
Retrospective Analysis of the Clinical Use and Benefit of Lenalidomide and Thalidomide in MyelofibrosisFranco Castillo-Tokumori, Chetasi Talati, Najla Al Ali, et al.
Pageof 13